New-onset bloody diarrhea, severe abdominal pain, fever, or significant changes in bowel patterns should prompt evaluation for UC flare rather than being attributed solely to medication side effects
This raises concerns about unsupervised use and highlights the need for caution until more safety data becomes available (2 Trusted Source Retatrutide-A Game Changer in Obesity Pharmacotherapy Go to source)
As of 2026, compounded tirzepatide is legally available only for patients with a documented medical need not met by FDA-approved Mounjaro or Zepbound, such as a verified allergy to an inactive ingredient
This treatment is highly effective for weight loss as it reduces hunger and promotes a feeling of fullness
On these sites you will find positive comments like the ones posted directly on their website but you will also find numerous negative comments and one star reviews claiming the product did not work
Crohns & Colitis Foundation